IXC 1.35% 7.5¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-224

  1. 1,403 Posts.
    lightbulb Created with Sketch. 282
    I have been in this game for awhile and I have never seen a company do a 180 like this. Their biggest upcoming risk was the readout after overcoming every single hurdle to the finish line. Unbelievable!! It's about as unlucky as you can get from an investor POV.
    Last edited by BalkanBroker: 03/07/23
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.